pI: 5.245 |
Length (AA): 194 |
MW (Da): 21774 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 190 | 2a22 (A) | 4 | 196 | 52.00 | 0 | 1 | 1.73 | -2.04 |
7 | 190 | 2a22 (A) | 4 | 196 | 52.00 | 0 | 1 | 1.69575 | -1.74 |
7 | 190 | 2a22 (A) | 4 | 196 | 51.00 | 0 | 1 | 1.69315 | -1.81 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst. | Otto TD Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 24 hs, early schizont, early trophozoite, late schizont, late trophozoite. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 16 hs, gametocyte, Ring, Sporozoite, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 8 hs, Male Gametocyte. | Otto TD Lasonder E |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127553)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G47810 | vacuolar protein sorting-associated protein 29 |
Babesia bovis | BBOV_III008970 | vacuolar protein sorting 29, putative |
Brugia malayi | Bm1_29865 | vacuolar protein sorting 29 |
Candida albicans | CaO19.13497 | Vacuolar protein sorting |
Candida albicans | CaO19.6076 | Vacuolar protein sorting |
Caenorhabditis elegans | CELE_ZK1128.8 | Protein VPS-29, isoform A |
Cryptosporidium hominis | Chro.70237 | vacuolar protein sorting 29 |
Cryptosporidium parvum | cgd7_2060 | vacuolar protein sorting 29 |
Dictyostelium discoideum | DDB_G0288787 | metallophosphoesterase domain-containing protein |
Drosophila melanogaster | Dmel_CG4764 | Vacuolar protein sorting 29 |
Echinococcus granulosus | EgrG_000780400 | Vacuolar protein sorting associated protein |
Entamoeba histolytica | EHI_025270 | vacuolar sorting protein 29 |
Echinococcus multilocularis | EmuJ_000780400 | Vacuolar protein sorting associated protein |
Giardia lamblia | GL50803_103855 | Vacuolar protein sorting 29 |
Homo sapiens | ENSG00000111237 | vacuolar protein sorting 29 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.32.1150 | vacuolar sorting-like protein |
Leishmania donovani | LdBPK_321110.1 | vacuolar sorting-like protein |
Leishmania infantum | LinJ.32.1110 | vacuolar sorting-like protein |
Leishmania major | LmjF.32.1050 | vacuolar sorting-like protein |
Leishmania mexicana | LmxM.31.1050 | vacuolar sorting-like protein |
Loa Loa (eye worm) | LOAG_03430 | hypothetical protein |
Mycobacterium leprae | ML2654 | conserved hypothetical protein |
Mus musculus | ENSMUSG00000029462 | vacuolar protein sorting 29 (S. pombe) |
Mycobacterium ulcerans | MUL_4792 | phosphoesterase |
Neospora caninum | NCLIV_022280 | vacuolar protein sorting 29, putative |
Oryza sativa | 4328954 | Os02g0265400 |
Plasmodium berghei | PBANKA_1035500 | vacuolar protein sorting-associated protein 29, putative |
Plasmodium falciparum | PF3D7_1406700 | vacuolar protein sorting-associated protein 29 |
Plasmodium knowlesi | PKNH_1351400 | vacuolar protein sorting-associated protein 29, putative |
Plasmodium vivax | PVX_086095 | vacuolar protein sorting-associated protein 29, putative |
Plasmodium yoelii | PY06431 | phosphoesterase, putative |
Saccharomyces cerevisiae | YHR012W | Vps29p |
Schistosoma japonicum | Sjp_0018680 | ko:K07095 vacuolar protein sorting 29, putative |
Schistosoma mansoni | Smp_050350.2 | hypothetical protein |
Schistosoma mansoni | Smp_050350.3 | hypothetical protein |
Schistosoma mansoni | Smp_050350.1 | hypothetical protein |
Schistosoma mansoni | Smp_050350.4 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.11.16000 | vacuolar sorting protein, putative |
Trypanosoma brucei | Tb927.11.14290 | vacuolar sorting protein, putative |
Trypanosoma congolense | TcIL3000.11.14600 | vacuolar sorting protein, putative |
Trypanosoma cruzi | TcCLB.511725.190 | vacuolar sorting protein, putative |
Toxoplasma gondii | TGME49_252490 | vacuolar protein sorting 29, putative |
Theileria parva | TP04_0799 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_378930 | vacuolar sorting protein vps29, putative |
Trichomonas vaginalis | TVAG_257380 | vacuolar sorting protein vps29, putative |
Trichomonas vaginalis | TVAG_108510 | vacuolar sorting protein vps29, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5900 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5900 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1035500 | Plasmodium berghei | Essential | plasmo |
TGME49_252490 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Pyoe003589; Recombinant protein: full-length; Source: P yoelii; vacuolar protein sorting 29, putative homolog ; Identifier: PY06431 |